M. Clark
发表
B. Gazzard,
M. Clark,
1978
.
P. Horrocks,
M. Clark,
1973,
Lancet.
R. Lindeman,
J. Colmore,
M. Clark,
1971,
Journal of gerontology.
P. N. Kaul,
M. Ticku,
M. Clark,
1972,
Journal of pharmaceutical sciences.
P. N. Kaul,
M. Clark,
M. Conway,
1970,
Journal of pharmaceutical sciences.
E. Serafetinides,
M. Clark,
D. Willis,
1972
.
E. Serafetinides,
M. Clark,
S. Collins,
1972,
The Journal of nervous and mental disease.
A. Ballinger,
M. Clark,
1994,
Metabolism: clinical and experimental.
R. Marks,
M. Clark,
R. Beard,
1967,
Lancet.
T. Whitsett,
M. Clark,
A. Czerwinski,
1973,
Postgraduate medical journal.
M. Clark,
P. H. Sampson,
T. S. Ray,
1962,
Journal of consulting psychology.
T. Whitsett,
M. Clark,
A. Czerwinski,
1972,
Clinical pharmacology and therapeutics.
E. Serafetinides,
M. Clark,
A. Czerwinski,
1974,
Clinical pharmacology and therapeutics.
J. P. Costiloe,
A. Paredes,
M. Clark,
1975,
Psychopharmacology communications.
E. Serafetinides,
J. Hewson,
J. Colmore,
1968,
Clinical pharmacology and therapeutics.
P. N. Kaul,
L. Whitfield,
M. Clark,
1978,
Journal of pharmaceutical sciences.
C. R. Doering,
M. Clark,
J. Hagans,
1957,
The Journal of laboratory and clinical medicine.
E. Serafetinides,
J. Colmore,
M. Clark,
1971,
Archives of general psychiatry.
E. Serafetinides,
M. Clark,
D. Willis,
1971,
International pharmacopsychiatry.
J. Colmore,
A. Kyriakopoulos,
M. Clark,
2004,
Psychopharmacologia.
J. P. Costiloe,
J. S. Chappell,
A. Paredes,
2004,
Psychopharmacologia.
D. Fowles,
E. Serafetinides,
M. Clark,
1970,
Clinical pharmacology and therapeutics.
J. P. Costiloe,
C. Smith,
A. Paredes,
1967,
Psychosomatic medicine.
Chlorpromazine in Chronic Schizophrenic Women: Rate of Onset and Rate of Dissipation of Drug Effects
R. Ragland,
M. Clark,
T. S. Ray,
1963,
Psychosomatic medicine.
M. Clark,
1985,
The Lancet.
M. Clark,
D. C. Mock,
Natoo Patel,
1963,
Clinical pharmacology and therapeutics.
C. R. Doering,
F. Ashley,
M. Clark,
1957,
Journal of Laboratory and Clinical Medicine.
M. Clark,
E. Schneider,
2005,
The American Journal of Digestive Diseases.
P. N. Kaul,
L. Whitfield,
M. Clark,
1978,
Journal of Pharmacokinetics and Biopharmaceutics.
P. N. Kaul,
M. Clark,
M. Conway,
1970,
Nature.
P. N. Kaul,
L. Whitfield,
M. Clark,
1976,
Journal of pharmaceutical sciences.
P. N. Kaul,
M. Ticku,
M. Clark,
1972,
Journal of pharmaceutical sciences.
J. P. Costiloe,
M. Clark,
J. Sullivan,
1972,
Diseases of the nervous system.
M. Allon,
M. Clark,
Michal L. Allon,
1990,
The American journal of psychiatry.
A. Ballinger,
M. Clark,
1994,
The Lancet.
P. N. Kaul,
L. Whitfield,
M. Clark,
1976,
Journal of pharmaceutical sciences.
J. P. Costiloe,
M. Clark,
D. Hill,
1975,
Diseases of the nervous system.
J. P. Costiloe,
A. Barrett,
A. Paredes,
1975,
Journal of clinical pharmacology.
J. P. Costiloe,
E. Serafetinides,
M. Clark,
1972,
Archives of general psychiatry.
E. Serafetinides,
J. Colmore,
M. Clark,
1971,
The Journal of clinical pharmacology and new drugs.
J. P. Costiloe,
A. Paredes,
R. Ragland,
1968,
Journal of chronic diseases.
E. Serafetinides,
R. Ragland,
M. Clark,
2004,
Psychopharmacologia.
M. Clark,
T. S. Ray,
W. Huber,
1968,
Clinical pharmacology and therapeutics.
R. Ragland,
M. Clark,
Adrian Kyriakopoiilos,
1970,
Pharmacologia Clinica.
T. Whitsett,
M. Clark,
A. Czerwinski,
1974,
Clinical pharmacology and therapeutics.
E. Serafetinides,
M. Clark,
D. Willis,
1972,
The Journal of nervous and mental disease.
Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
E. Serafetinides,
M. Clark,
1971,
Diseases of the nervous system.